Latest filing published 09 Dec 2022 for Celldex Therapeutics, Inc., €595k.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 5 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +254.3%Entry US$8.76 · Close at T+365 US$31.04
- -68.6%Entry US$8.85 · Close at T+365 US$2.78
- -24.6%Entry US$54.90 · Close at T+365 US$41.40
- +57.0%Entry US$43.65 · Close at T+365 US$68.55
- -28.9%Entry US$57.15 · Close at T+365 US$40.65
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Tibor Keler: trading record in brief
This profile gathers the share dealings of Tibor Keler in Celldex Therapeutics, Inc. We count 8 filings; the first trade dates from 6 January 2009 and the latest from 7 December 2022.
Market trades split into 5 purchases (€53k) and 1 sale (€595k). On balance, insiders were net sellers of €542k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 1 share grant and 1 option exercise. Since January 2022: no purchases and 1 sale on the market.
A typical purchase (the median) is worth €8,892. Clusters matter here: 1 out of 3 purchases overlapped with buying by a colleague within 30 days. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase. For 5 purchases whose 90-day window has closed, the share price was higher on day 90 than the day after publication in 60% of cases, with a median move of +7.9%. Past outcomes like these are no guarantee of what comes next.
The newest entry dates from 9 December 2022: an open-market sale of €595k, in Celldex Therapeutics, Inc. The last insider purchase was made public on 10 June 2020, 2,343 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Tibor Keler
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 16,860 shares@ US$36.9388.8% of flowCommon Stock, par value $0.001 per shareSEC:0001415889-22-012301:1
- 16,860 shares@ US$2.78100.0% of flowCommon Stock, par value $0.001 per shareSEC:0001415889-22-012301:0
- 5,000 shares@ US$2.9922.8% of flowCommon Stock, par value $0.001 per shareSEC:0001179110-20-007164:0Canonical exit: 7 Sept 2020 (T+90)
- 16,500 shares@ US$0.592912.7% of flowCommon Stock, par value $0.001 per shareSEC:0001179110-18-008669:0Canonical exit: 13 Sept 2018 (T+90)
- 3,000 shares@ US$3.3211.8% of flowCommon Stock, par value $0.001 per shareSEC:0001179110-16-029306:0Canonical exit: 1 Dec 2016 (T+90)
- 5,000 shares@ US$2.50Common StockSEC:0001179110-11-012075:0Canonical exit: 9 Nov 2011 (T+90)
- 5,000 shares@ US$3.52Common StockSEC:0001179110-10-013711:0Canonical exit: 12 Dec 2010 (T+90)
- 5,868 sharesCommon StockSEC:0001179110-09-000774:0
8 of 8 declarations